Daily markets, macro & broker intelligence
Twist Bioscience CEO Emily Leproust has offloaded $56.3 million worth of company shares, triggering fresh scrutiny over insider sentiment at one of synthetic biology's most closely watched names. Here's what the transaction means for TWST price action and the broader genomics sector.
Join our list for market analysis and broker insights. No spam.
Twist Bioscience CEO Emily Leproust has offloaded $56.3 million worth of company shares, triggering fresh scrutiny over insider sentiment at one of synthetic biology's most closely watched names. Here's what the transaction means for TWST price action and the broader genomics sector.
Avenue RP Opportunities Fund has disclosed a $1.49 million position in XBP Global Holdings, a move that signals fresh institutional conviction in a name that operates at the intersection of document digitisation, fintech infrastructure, and enterprise services. The purchase raises important questions about valuation, timing, and where the stock goes from here.
A director at Arcutis Biotherapeutics has sold approximately $114,000 worth of company stock, drawing attention from traders who track insider activity as a sentiment signal. Here is what the transaction reveals about the stock's near-term risk profile.
Global bond yields pulled back as a Fed rate hike and a surprise BoE hold created a split-policy dynamic that is reshuffling currency positioning across major pairs. Here is the full breakdown of why it matters and what to watch next.
The Uganda shilling is facing intensifying selling pressure as corporate and importer dollar demand outstrips local supply, raising the stakes for traders watching emerging-market African forex pairs in Q3 2026.
The US dollar's six-session rally ran out of steam on September 17, 2026, after the Federal Reserve delivered its latest rate hike — a classic 'buy the rumour, sell the fact' unwind. Meanwhile, sterling came under renewed pressure after the Bank of England opted to hold rates, signalling a clear policy divergence between Washington and London.
President Trump's willingness to accept expanded ethics guardrails and state enforcement powers has breathed new life into the Clarity Act, the most consequential piece of U.S. crypto legislation in years. Traders are now repricing regulatory risk across digital assets.
Bitwise's BWOW Dogecoin ETF is closing its doors after failing to attract meaningful buyer interest, exposing a structural divide in the altcoin ETF market as XRP and Solana funds collectively haul in $3 billion. The question isn't just about DOGE — it's whether meme-coin ETFs solve any real investment problem.
Bitmine has deployed $68 million in fresh ether purchases, pushing toward a stated 5% accumulation threshold as Fundstrat's Tom Lee argues the ETH-BTC ratio and accelerating institutional inflows create a compelling setup for further gains.
Broadcom's quarterly revenue guidance came in below Wall Street estimates, triggering a re-rating of semiconductor sentiment and sending ripple effects through equity indices, industrial metals, and energy commodities tied to AI infrastructure demand.
Bond vigilantes are reasserting discipline across global sovereign debt markets, pushing yields to levels that threaten fiscal sustainability and commodity demand outlooks. Here is what traders need to understand right now.
Cettire delivered on its H2 2026 revenue forecast, triggering a sharp share price rally and renewed interest from momentum traders. Here is what the numbers mean and where the stock heads next.
Royal Mail has once again fallen short of Ofcom's delivery targets, even as parent company International Distributions Services points to incremental operational improvements. For traders and investors, the miss keeps regulatory and financial pressure squarely on IDS and raises broader questions about the viability of UK legacy logistics infrastructure.
The UK economy expanded 0.4% in the April-to-June quarter of 2026, with warm weather and World Cup-related consumer spending providing a measurable lift to hospitality, retail and leisure sectors. Traders are now repricing Bank of England rate-cut expectations and reassessing the outlook for sterling and UK equities.
A legal challenge to Truth Social's premium tier — which sells early access to Donald Trump's market-moving social posts — strikes at the heart of information asymmetry in modern markets. Here's what traders and investors need to understand right now.
Pinterest co-founder and director Benjamin Silbermann has offloaded $2.18 million in company stock, reigniting debate about insider conviction at current price levels. Traders are now scrutinising whether this sale signals caution at the top or is simply routine portfolio management.
Goldman Sachs has agreed to acquire NEOS Investments for $2.25 billion, vaulting its derivatives-based ETF platform to $130 billion in assets and putting it on a direct collision course with BlackRock in the fast-growing bitcoin income ETF space.
AAON posted a Q2 earnings beat but immediately tempered market enthusiasm by cutting its forward margin guidance, citing persistent cost pressures. The divergence between headline results and the forward outlook sets up a classic earnings trap — here is how to navigate it.
The US Senate is preparing to subject Donald Trump's pick to lead the nation's intelligence apparatus, John Clayton, to tough questioning over the potential use of subpoenas against journalists. The confirmation hearing is shaping up to be a flashpoint for press freedom advocates and civil liberties groups alike.
Inflation reports are among the most market-moving economic releases on the calendar. This definitive guide explains exactly what CPI and PPI measure, why traders watch them obsessively, and how each data point ripples through stocks, bonds, currencies and commodities — with real examples and actionable steps.
Short selling lets traders profit when asset prices fall — but it comes with unique risks most investors never face. This definitive guide explains exactly how short selling works, walks through a real-world example, compares it to going long, and gives you the practical steps and pitfalls you need to know before ever borrowing a share.
SoFi is a US-based fintech powerhouse offering commission-free investing, banking, and lending under one roof — but is it the right choice for active traders? Our 2026 SoFi review breaks down everything you need to know.
Trading212 Invest is a commission-free stock and ETF investing platform that has attracted millions of retail investors across Europe and beyond. This review examines its safety credentials, cost structure, platform quality, and overall value in 2026.
TD Ameritrade, now fully integrated into Charles Schwab, remains one of the most feature-rich brokerage platforms available to U.S. investors and active traders in 2026. This review covers everything from thinkorswim's advanced charting to zero-commission stock trading and robust investor protections.